Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria

NCT02353494 · clinicaltrials.gov ↗

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Plasmodium Falciparum Infection
Plasmodium Vivax Infection

Interventions

DRUG: Dihydroartemisinin-Piperaquine

Sponsor

Menzies School of Health Research

Collaborators

[object Object]
[object Object]